Notably, previous studies in diverse cancer models have identified Rap2B as a multifunctional GTPase that directly drives tumorigenic processes, such as enhancing proliferation via activation of the ERK/MAPK and PI3K/Akt signaling pathways [21–23, 41]. The gene discussed is AKT1; the disease is cancer.